date:Mar 04, 2014
Developer and manufacturer of marine-derived omega-3 polyunsaturated fatty acids Neptune has priced an underwritten public offering of 10,000,000 newly issued common shares at a public offering price of US$2.50 per share.
The gross proceeds to Neptune are expected to be approximately US$25 million.
Neptune said that it intends to allocate approximately US$10 million for sales, marketing and distribution of its krill oil products, approximately US$5 million to support one of its subsidiaries, N